224 related articles for article (PubMed ID: 26998906)
1. Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
Chow LN; Schreiner P; Ng BY; Lo B; Hughes MR; Scott RW; Gusti V; Lecour S; Simonson E; Manisali I; Barta I; McNagny KM; Crawford J; Webb M; Underhill TM
PLoS One; 2016; 11(3):e0151765. PubMed ID: 26998906
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
Shu HK; Yoon Y; Hong S; Xu K; Gao H; Hao C; Torres-Gonzalez E; Nayra C; Rojas M; Shim H
PLoS One; 2013; 8(11):e79768. PubMed ID: 24244561
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
Song JS; Kang CM; Kang HH; Yoon HK; Kim YK; Kim KH; Moon HS; Park SH
Exp Mol Med; 2010 Jun; 42(6):465-72. PubMed ID: 20498529
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
Makino H; Aono Y; Azuma M; Kishi M; Yokota Y; Kinoshita K; Takezaki A; Kishi J; Kawano H; Ogawa H; Uehara H; Izumi K; Sone S; Nishioka Y
J Med Invest; 2013; 60(1-2):127-37. PubMed ID: 23614921
[TBL] [Abstract][Full Text] [Related]
5. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:A study in vitro and in vivo.
Qin L; Qin J; Zhen X; Yang Q; Huang L
Biomed Pharmacother; 2018 May; 101():599-607. PubMed ID: 29518606
[TBL] [Abstract][Full Text] [Related]
6. The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis.
Amano H; Mastui Y; Ito Y; Shibata Y; Betto T; Eshima K; Ogawa F; Satoh Y; Shibuya M; Majima M
Biomed Pharmacother; 2019 Sep; 117():109067. PubMed ID: 31176171
[TBL] [Abstract][Full Text] [Related]
7. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
Phillips RJ; Burdick MD; Hong K; Lutz MA; Murray LA; Xue YY; Belperio JA; Keane MP; Strieter RM
J Clin Invest; 2004 Aug; 114(3):438-46. PubMed ID: 15286810
[TBL] [Abstract][Full Text] [Related]
8. G-CSF Inhibits Pulmonary Fibrosis by Promoting BMSC Homing to the Lungs via SDF-1/CXCR4 Chemotaxis.
Zhao FY; Cheng TY; Yang L; Huang YH; Li C; Han JZ; Li XH; Fang LJ; Feng DD; Tang YT; Yue SJ; Tang SY; Luo ZQ; Liu W
Sci Rep; 2020 Jun; 10(1):10515. PubMed ID: 32601321
[TBL] [Abstract][Full Text] [Related]
9. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.
Xu J; Mora A; Shim H; Stecenko A; Brigham KL; Rojas M
Am J Respir Cell Mol Biol; 2007 Sep; 37(3):291-9. PubMed ID: 17463394
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation.
Watanabe M; Matsuyama W; Shirahama Y; Mitsuyama H; Oonakahara K; Noma S; Higashimoto I; Osame M; Arimura K
J Immunol; 2007 May; 178(9):5888-98. PubMed ID: 17442973
[TBL] [Abstract][Full Text] [Related]
11. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.
Mehrad B; Burdick MD; Strieter RM
Int J Biochem Cell Biol; 2009; 41(8-9):1708-18. PubMed ID: 19433312
[TBL] [Abstract][Full Text] [Related]
12. The
Pansy K; Feichtinger J; Ehall B; Uhl B; Sedej M; Roula D; Pursche B; Wolf A; Zoidl M; Steinbauer E; Gruber V; Greinix HT; Prochazka KT; Thallinger GG; Heinemann A; Beham-Schmid C; Neumeister P; Wrodnigg TM; Fechter K; Deutsch AJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554271
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
Liepelt A; Tacke F
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
[TBL] [Abstract][Full Text] [Related]
14. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo.
Macoska JA; Wang Z; Virta J; Zacharias N; Bjorling DE
Prostate; 2019 May; 79(7):757-767. PubMed ID: 30811623
[TBL] [Abstract][Full Text] [Related]
16. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.
Ding BS; Cao Z; Lis R; Nolan DJ; Guo P; Simons M; Penfold ME; Shido K; Rabbany SY; Rafii S
Nature; 2014 Jan; 505(7481):97-102. PubMed ID: 24256728
[TBL] [Abstract][Full Text] [Related]
17. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.
Aono Y; Kishi M; Yokota Y; Azuma M; Kinoshita K; Takezaki A; Sato S; Kawano H; Kishi J; Goto H; Uehara H; Izumi K; Nishioka Y
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):793-801. PubMed ID: 24885373
[TBL] [Abstract][Full Text] [Related]
18. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
[TBL] [Abstract][Full Text] [Related]
19. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
[TBL] [Abstract][Full Text] [Related]
20. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]